(Q55472725)

12 July 2018

title

Loss of heterozygosity of a locus in the chromosomal region 17p13.3 is associated with increased cell proliferation in astrocytic tumors. (English)

1 reference

12 July 2018

1 reference

Chitra Sarkar

1

1 reference

12 July 2018

Parthaprasad Chattopadhyay

2

1 reference

12 July 2018

Angela Mercy Ralte

3

1 reference

12 July 2018

Ashok K Mahapatra

4

1 reference

12 July 2018

Subrata Sinha

5

1 reference

12 July 2018

publication date

1 July 2003

1 reference

12 July 2018

Cancer Genetics and Cytogenetics

published in

1 reference

12 July 2018

volume

144

1 reference

12 July 2018

issue

2

1 reference

12 July 2018

page(s)

156-164

1 reference

12 July 2018

p53 mutations in human cancers

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Role of 17p13.3 chromosomal region in determining p53 protein immunopositivity in human astrocytic tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

p53 mutations in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Genetic basis for p53 overexpression in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Expression and mutation analysis of the p53 gene in uterine papillary serous carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Comparative study of p53 gene and protein alterations in human astrocytic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

TP53 alterations and clinical outcome in low grade astrocytomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

p53 immunoreactivity in astrocytomas and its relationship to survival

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Proliferative potential and outcome in pediatric astrocytic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Proliferative potential and prognostic evaluation of low-grade astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

In-vivo proliferative potential of primary human brain tumors; its correlation with histological classification and morphological features: I. Gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Morphological appearance, growth kinetics and glial fibrillary acidic protein (GFAP) expression in primary in vitro explant culture of astrocytic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

A correlative study of in vivo and in vitro labeling index using bromodeoxyuridine in human brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

p53 gene mRNA expression and chromosome 17p allele loss in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Monoclonal antibody Ki-67: its use in histopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: A comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: a Ki-67 study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Postoperative radiotherapy of supratentorial low-grade gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Prognostic implications of the proliferative potential of low-grade astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Comparison of three quantitation methods for PCNA immunostaining: applicability and relation to survival in 83 astrocytic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Statistical modelling in analysis of prognosis in glioblastoma multiforme: a study of clinical variables and Ki-67 index

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

p53 protein in low-grade astrocytomas: a study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Recurrent astrocytic tumours--a study of p53 immunoreactivity and malignant progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Prognostic implications of p53 overexpression in supratentorial astrocytic tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

Rearranged p53 gene with loss of normal allele in a low-grade nonrecurrent glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900937-8

7 January 2021

10.1016/S0165-4608(02)00937-8

Identifiers

DOI

1 reference

12 July 2018

1 reference

12 July 2018